Home Chiral Solifenacin CS-DV-00009

(+)-(R)-Quinuclidin-3-yl [2-(2-benzoylphenyl)ethyl]carbamate

Chiral API Family: Solifenacin CAT No. CS-DV-00009 CAS No. 1956436-64-8
In Stock
Product Detail

(+)-(R)-Quinuclidin-3-yl [2-(2-benzoylphenyl)ethyl]carbamate

Solifenacin Chiral
Stock Status: In Stock  Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category Chiral
API Family Solifenacin
Storage Store at refrigerator (2-8°C) for long term storage
Hazard Information Refer MSDS for accurate information.

(+)-(R)-Quinuclidin-3-yl [2-(2-benzoylphenyl)ethyl]carbamate Product Information

(+)-(R)-Quinuclidin-3-yl [2-(2-benzoylphenyl)ethyl]carbamate is listed under Chiral. It is associated with Solifenacin and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-DV-00009.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.

Technical Data

Product Name
(+)-(R)-Quinuclidin-3-yl [2-(2-benzoylphenyl)ethyl]carbamate
CAS No.
1956436-64-8
CAT No.
CS-DV-00009
Molecular Formula
C₂₃H₂₆N₂O₃
Molecular Weight
378.46
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O=C(O[C@H]1C[N@]2CC[C@]1([H])CC2)NCCC3=CC=CC=C3C(C4=CC=CC=C4)=O
IUPAC Name
(1S,3R,4S)-quinuclidin-3-yl (2-benzoylphenethyl)carbamate
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.

Description

Overview
Useful research chemical for a range of applications.
Synonyms
(1S,3R,4S)-quinuclidin-3-yl (2-benzoylphenethyl)carbamate
Application Notes
Useful research chemical for a range of applications.
References
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.